Parkinson’s disease treatment with a standard protocol by Israeli doctors (Alishech Clinic, Israel)
Any treatment for Parkinson's disease aims to slow the rate of deterioration and to prevent complications of the disease. The ultimate goal of treatment is a modification of the pathological process, therefore slowing the progression of the disease, and preventing motor and non-motor complications in the advanced stage of Parkinson's disease. In September 2009, the New England Journal of Medicine, one of the most influential medical journals, published a work proving that early treatment with Rasagiline (Azilect) at a dosage of 1 mg/day had a good effect on slowing the deterioration rate of the disease.
There’s currently a treatment involving intracerebral injections of viral vectors, which are carriers of therapeutic genes, and growth factor transfer method to strengthen the activity of dopaminergic terminals residues; however, these are in the research stage. Rehabilitation treatment opens up a good prospect for future treatment; though unfortunately, there are more questions than answers at this stage. This also raises questions about reliability, and it is not clear how much this treatment can affect non-motor symptoms of Parkinson's disease. Of great importance is Primary Neuroprotection, which deals with preventing or delaying the start of the disease. Clear markers of Parkinson’s disease risk are currently unknown; therefore, it is impossible to conduct neuroprotective studies for people with possible risk of developing Parkinson’s disease.
The preclinical stage of the disease has a duration of almost six years. This window of time gives us a good chance for neuroprotective treatment. Marker Detection Studies in the preclinical stage of Parkinson's disease are becoming more important. Physical activity is essential for the modification of the disease’s progression. Intense physical activity, as shown in many clinical studies, helps delay the development of Parkinson’s disease in men.
Azilect is currently prescribed in Israel to each patient in the initial stage of Parkinson's disease as the first line treatment. Taking 1 mg of Azilect at night is proven to suspend the development of Parkinson’s disease for several years. Therefore, this is the first line of treatment for the diagnosed disease.
Home treatment guideline under Dr. Israel Levin online supervision
Azilect 1 mg – take 1 pill at night.
Active component: Rasagiline 1 mg, 90 pills (3 packs for a 3-month course)
Total sum: $360 to purchase. Manufacturer: Teva Pharmaceutical, Israel
Second line drugs:
If you have had the disease for several years, you need to start taking the second-line drugs: Levodopa in different combinations. Levodopa is dopamine precursor, which turns into it inside the human body. Levodopa in different combinations is currently the most effective medication for Parkinson's disease treatment when all symptoms of the disease are manifested. Levodopa is prescribed in a dosage of 125 mg, 3 times a day. Depending on the response, the dose can be increased. The optimal dose is considered to be 750-1250 mg/day. If Sinemet is prescribed its dosage is 200 mg, twice a day.
100% Delivery Guarantee
Each customer is given a tracking number which will allow him to monitor the process of delivery in the tracking system.
Delivery to any city in the word; delivery time is 2-14 days after payment.
*The delivery of medications is possible only on the prescription of a doctor from the clinic Alisheh VMC.
*If the parcel has not been delivered, the receiver will be refunded the full order amount. The receiver may cancel the order if the order has been paid for through the PayPal system installed on the website.
* If a parcel is rejected by the receiver after its reception, the return will not be accepted.
* Alishech shall not be liable for product misuse.
* Patients taking the aforementioned remedy know that they suffer from the aforementioned disease.
* Having chosen to purchase the aforementioned remedy, the customer is enabled to receive treatment with Israeli remedies without coming to Israel (which allows a significant reduction of expenses).
Alishech Virtual Medical Clinic
Advanced healing guidelines for self treatment at home
Alishech is a reliable company engaged in medical tourism sphere in Israel.
Alishech organizes a logical transportation of different degrees of patients from around the world to the best clinics and hospitals in Israel.
Alishech provide Second Medical Opinion Service and supply medicines to it's clients
Alishech N.C. Company Number 51-48730-7. Tax Number N.T.I. 952470268.
Melinepa Medical Services N.C. Company Number 51-283885-5 Tax Number N.T.I. 952347631.